Akebia Therapeutics, Inc. (AKBA) financial statements (2020 and earlier)

Company profile

Business Address 245 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:146322318260139109
Cash and cash equivalents123105701875033
Short-term investments23217248738976
Other undisclosed cash, cash equivalents, and short-term investments 0 000
Receivables30173434 0
Inventory, net of allowances, customer advances and progress billings116114    
Inventory116114    
Other undisclosed current assets8166221
Total current assets:299468358296141110
Noncurrent Assets
Operating lease, right-of-use asset30
Property, plant and equipment1384310
Long-term investments and receivables     40
Long-term investments     40
Intangible assets, net (including goodwill)355383    
Goodwill5555    
Intangible assets, net (excluding goodwill)300328    
Deferred costs     1
Other noncurrent assets981372110
Other undisclosed noncurrent assets    0(41)
Total noncurrent assets:4965286421
TOTAL ASSETS:795997364300143111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1911945932129
Accounts payable64437222
Accrued liabilities1271515230105
Employee-related liabilities     2
Deferred revenue32
Debt 15    
Postemployment benefits liability     0
Deferred revenue and credits8582  
Contract with customer, liability57
Other undisclosed current liabilities     (2)
Total current liabilities:223266144114127
Noncurrent Liabilities
Long-term debt and lease obligation29     
Operating lease, liability29
Liabilities, other than long-term debt748810111800
Deferred revenue and credits101118  
Deferred revenue44
Contract with customer, liability56
Deferred rent credit 3
Other liabilities30300000
Other undisclosed noncurrent liabilities27    
Total noncurrent liabilities:1059510111800
Total liabilities:328361245232127
Stockholders' equity
Stockholders' equity attributable to parent, including:46863611968131104
Common stock00    
Treasury stock, value    (0)(0)
Additional paid in capital1,1671,151494365293205
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)(0)
Accumulated deficit(700)(514)(374)(297)(161)(101)
Other undisclosed stockholders' equity attributable to parent     0
Total stockholders' equity:46863611968131104
TOTAL LIABILITIES AND EQUITY:795997364300143111

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues3252081782 1
Revenue, net1782 1
Cost of revenue(107)(8)    
Cost of goods and services sold(80)(6)    
Other undisclosed gross profit(8)     
Gross profit:2102001782 1
Operating expenses(492)(378)(258)(138)(62)(38)
Other undisclosed operating loss     (1)
Operating loss:(282)(178)(80)(136)(62)(38)
Nonoperating income (expense)(0)0010 
Investment income, nonoperating   1  
Other nonoperating income (expense)(0)00(0)0 
Loss from continuing operations before equity method investments, income taxes:(282)(178)(80)(136)(61)(38)
Other undisclosed income from continuing operations before income taxes86    
Loss from continuing operations before income taxes:(274)(172)(80)(136)(61)(38)
Income tax benefit528    
Other undisclosed income from continuing operations28     
Net loss:(241)(144)(80)(136)(61)(38)
Other undisclosed net income (loss) attributable to parent(4) 3 11
Net loss attributable to parent:(245)(144)(77)(136)(61)(37)
Preferred stock dividends and other adjustments     (87)
Other undisclosed net loss available to common stockholders, basic     (0)
Net loss available to common stockholders, diluted:(245)(144)(77)(136)(61)(124)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(241)(144)(80)(136)(61)(38)
Other comprehensive loss     (0)
Comprehensive loss:(241)(144)(80)(136)(61)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(4)02(0)01
Comprehensive loss, net of tax, attributable to parent:(245)(143)(77)(136)(61)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: